Literature DB >> 9792950

Recombinant human erythropoietin in the treatment of chronic anemia of cancer.

S Yalçin, B Orhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9792950     DOI： 10.1159/000040883

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  3 in total

1.  Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin.

Authors:  Suayib Yalcin; Sevda Müftüoğlu; Eren Cetin; Banu Sarer; Berna Akkuş Yildirim; Dilara Zeybek; Bülent Orhan
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

2.  Protective effect of amifostine against cisplatin-induced motor neuropathy in rat.

Authors:  Suayib Yalcin; Gulay Nurlu; Bülent Orhan; Dilara Zeybek; Sevda Müftüoğlu; Banu Sarer; Berna Akkuş Yildirim; Eren Cetin
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats.

Authors:  Bulent Orhan; Suayib Yalcin; Gulay Nurlu; Dilara Zeybek; Sevda Muftuoglu
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.